Clinical Trial Update: Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

The document reports Phase 3 trial results on the efficacy and safety of a once-weekly exenatide suspension in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exenatide Once Weekly Suspension (exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-09-16